- Life Sciences - 18:00 Clean house
- Medicine - 13:00 Depression in pregnancy increases risk of mental health problems in children
- Medicine - 12:00 UK lags behind Europe in supporting and prolonging cycling among older population
- Medicine - 09:00 Rest and well- being – world’s largest survey
- Medicine - 06:00 Outdoor air pollution exceeds WHO limits for 90% of UK population
- Medicine - Sep 27 Researchers close in on new ways to prevent child tooth decay
- Medicine - Sep 27 Study offers new data tool- kit for Ebola outbreak zones
- Medicine - Sep 26 BAME patients may be underrepresented in trials for diabetes treatment, study finds
- Life Sciences - Sep 26 An unobstructed view into the human body
- Medicine - Sep 26 Cancer killers: C’dots show ability to induce cell death in tumors
- Medicine - Sep 26 Experts provide insight into the spread and prevention of infectious diseases
- Medicine - Sep 26 £160 million Cancer Centre opens at Guy's Hospital
- Medicine - Sep 26 Pinpointing a brain circuit that can keep fears at bay
- Medicine - Sep 23 Novartis receives three new FDA approvals for the expanded use of Ilaris treating rare Periodic Fever Syndrome conditions
- Medicine - Sep 23 Compared with Europe, American teens have high rates of illicit drug use
- Careers - Sep 23 Treatment withdrawal from patients in a permanent vegetative state
Ageing population could boost economy
Older people are a benefit, rather than a burden, to the economy and society according to a new report from the UCL School of Pharmacy.
The report, Active Ageing: Live Longer and Prosper (produced with financial support from Alliance Boots) refutes the view that older people are a major source of economic problems such as reduced international competitiveness. It provides evidence that the benefits of living longer will outweigh the additional health and social care costs of population ageing.
"All too often old age is seen as a time of increasing dependency, vulnerability and frailty. But older people already contribute significantly to their families’ and wider communities’ wellbeing," said Jennifer Gill (UCL School of Pharmacy), co-author of the report.
Life expectancy at 65 has increased by six years since the 1950s. As people live longer they stay healthier, at any given age. Such advances have partly been generated by the pharmaceutical revolution of 1950-2000. Medicines for conditions such as heart attacks, strokes and diabetes, are now well understood and have already contributed significantly to falling death and disability rates, despite problems such as obesity.
"In future decades, greater participation by people in their 60s and 70s in formal and informal work, alongside additional decreases in the number of life years spent with major disabilities, could increase national productivity by up to 10 per cent of GDP," said Gill.
All too often old age is seen as a time of increasing dependency, vulnerability and frailty. But older people already contribute significantly to their families’ and wider communities’ wellbeing
In the 1980s and 1990s estimates indicate that just 0.2% of the annual increase in NHS spending was caused by population ageing. Even though the current figure is in the order of one per cent per annum such cost increases have been outweighed by the positive contribution of £40 billion that adults aged 65 and over made to the British economy in 2010. It is estimated that by 2030 retired ’baby boomers’ will contribute £80 billion to the economy.
An increasing policy emphasis on extending healthy life expectancy as an explicitly planned, high priority objective, will lead to even higher ’pay-backs’. Extended community pharmacy and other community based services that support the adoption of protective lifestyles as well as increased levels of safe and effective medicine and vaccines use would help increase healthy life expectancy faster than overall life expectancy.
"Population ageing and increasing longevity are now world-wide phenomena. In the future, integrated life-long preventive care and support will enable resources like community pharmacies and community nursing to be used to optimum effect, permitting progressively longer healthy life expectancies," said co-author Professor David Taylor (UCL School of Pharmacy).
Challenges such as rising Alzheimer’s disease prevalence rates and the need to provide good quality social care on an affordable and equitable basis are substantial. But improved diagnostic products and further generations of new pharmaceuticals will in time reduce the extent of the disability experienced as ageing continues.
"Even when older people do need long term supportive care, it will be affordable," said Professor Taylor. "For instance, the extra public cost of the recent Dilnot proposals for making residential and community care more fairly available in England would, if implemented, probably be under 0.2 per cent of current UK Gross National Product."
: George Wigmore
UCL School of Pharmacy
Professor David Taylor
Last job offers
- Medicine/Pharmacology - 15.9
Leiter/in Forschung & Entwicklung Pflege (Professorenstelle)
- Medicine/Pharmacology - 15.9
Leiter/in des Studiengangs Master of Science in Pflege
- Architecture - 14.9
Wissenschaftle/r Mitarbeiter/in oder Postdoktorand/in im Bereich Architekturvermittlung
- Life Sciences - 11.9
Postdoctoral Research Fellowship
- Medicine/Pharmacology - 7.9
Software Systems Requirements Engineer - Medical Device
- Business/Economics - 19.8
Faculty Position in Business Analytics
- Business/Economics - 26.9
Postdoc position ’Environmental Economics’ (1.0 FTE)
- Medicine/Pharmacology - 26.9
856457 Associate Professor of Epidemiology